Population Council

Trends in GLP ‐1 Receptor Agonist Prescribing Without an Apparent FDA ‐Approved Indication

ABSTRACT Objective This study evaluated temporal trends and patient characteristics associated with glucagon‐like peptide‐1 (GLP‐1) receptor agonist prescribing among US adults without an apparent FDA‐approved indication. Methods This retrospective cohort study used Cosmos electr...

Mapping implementation science in Pakistan’s health sector: a scoping review of frameworks, strategies, and implementation outcomes

This scoping review mapped how implementation science and implementation-relevant research have been used in Pakistan's health sector. Searches of PubMed, Google Scholar, PakMediNet, WHO IRIS, and major Pakistani institutional repositories identified English-language studies publ...

Shifting social norms, behavioural intentions and opposition to female genital mutilation: Effectiveness of layered community interventions in a high prevalence setting in Kenya

Female genital mutilation (FGM) remains prevalent in parts of Kenya, sustained by social norms around marriageability and social belonging. Although community interventions to end FGM are widely implemented, quantitative evidence of their effectiveness remains limited. This study...

Trends in GLP-1 Receptor Agonist Prescriptions for Children Ages 8 to 11 With Obesity: 2019–2026

BACKGROUND AND OBJECTIVES: Clinical practice guidelines for pediatric obesity management allow for consideration of glucagon-like peptide-1 receptor agonists (GLP-1RA) in children ages 8-11. No study has documented secular trends in GLP-1RA prescribing in this group. We hypothesi...

The Long Arm of Incarceration: Incarceration History and Mortality Risk in a Nationally Representative Cohort of Older US Adults, 2012-2022.

. 2026;116(8):1234-1243. https://doi.org/10.2105/AJPH.2026.308449).